Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Ferrentino

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Gastroenterology|May 2, 2002
Angiotensin receptor antagonists in portal hypertension: fog over paradiseChristian A Speer, Nicholas Ferrentino
International Journal of Surgical Pathology|August 31, 2016
Russell Body Inflammatory PolypRyan F Coates, Nicholas Ferrentino, Michelle X Yang
Journal of Viral Hepatitis|February 26, 2019
Utility of laboratory monitoring during hepatitis C treatment with ribavirin-free direct-acting antiviral regimensJocelyn R VanOpdorp, Nicholas Ferrentino, Doris B Strader, et al.
Journal of Hepatology|August 6, 2005
Peginterferon alfa-2b and ribavirin for treatment-refractory chronic hepatitis CEdward L Krawitt, Takamaru Ashikaga, Stuart R Gordon, et al.
Pharmacotherapy|July 29, 2008
Frequency of inappropriate continuation of acid suppressive therapy after discharge in patients who began therapy in the surgical intensive care unitCatherine E Murphy, Alison M Stevens, Nicholas Ferrentino, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Gastroenterology|May 2, 2002
Angiotensin receptor antagonists in portal hypertension: fog over paradiseChristian A Speer, Nicholas Ferrentino
International Journal of Surgical Pathology|August 31, 2016
Russell Body Inflammatory PolypRyan F Coates, Nicholas Ferrentino, Michelle X Yang
Journal of Viral Hepatitis|February 26, 2019
Utility of laboratory monitoring during hepatitis C treatment with ribavirin-free direct-acting antiviral regimensJocelyn R VanOpdorp, Nicholas Ferrentino, Doris B Strader, et al.
Journal of Hepatology|August 6, 2005
Peginterferon alfa-2b and ribavirin for treatment-refractory chronic hepatitis CEdward L Krawitt, Takamaru Ashikaga, Stuart R Gordon, et al.
Pharmacotherapy|July 29, 2008
Frequency of inappropriate continuation of acid suppressive therapy after discharge in patients who began therapy in the surgical intensive care unitCatherine E Murphy, Alison M Stevens, Nicholas Ferrentino, et al.
Pageof 1